Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-20 · accession 0001209191-23-012323 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-23 | 2023-02-20 | USPH | Williams Eric Joseph | Co-Chief Ops Off | A - Grant | $0.00 | +5,000 | 13.9K | +56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-20 | A | A | 5,000 | $0.00 | 13,864 | D | — | — | (F1) The 5,000 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installments with 312 shares vesting on the first day of each of the succeeding fifteen quarters beginning on April 1, 2023, and with the final 320 shares vesting on January 1, 2027, if he is employed by the Company on those dates. (F2) Includes 9,036 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 624 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, January 1, 2024, April 1, 2024, July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025; 908 shares on July 1, 2025; 624 shares on October 1, 2025; 632 shares on January 1, 2026; and 312 shares on April 1, 2026, July 1, 2026 and October 1, 2026 and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates. |